Disc Medicine
IRON
236 hedge funds and large institutions have $2.86B invested in Disc Medicine in 2026 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 94 increasing their positions, 59 reducing their positions, and 23 closing their positions.
91% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 23
59% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 59
23% more capital inflows, than outflows
Capital inflows: $353M | Capital outflows: $287M
11% more call options, than puts
Call options by funds: $83.1M | Put options by funds: $75.2M
8% more funds holding
Funds holding: 218 → 236 (+18)
1.5% more ownership
Funds ownership: 112.08% → 113.58% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$55.6M |
| 2 |
Two Sigma Investments
New York
|
+$32.8M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$18.1M |
| 4 |
Jane Street
New York
|
+$17.3M |
| 5 |
First Turn Management
Del Mar,
California
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BVF Inc
San Francisco,
California
|
-$69.5M |
| 2 |
Frazier Life Sciences Management
Palo Alto,
California
|
-$31.7M |
| 3 |
OrbiMed
New York
|
-$26.2M |
| 4 |
Jennison Associates
New York
|
-$21.5M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$19.6M |
IRON Hedge Fund Activity: Q3 2026 in Review
236 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q3 2026, worth a combined $2.86B — down 8.8% from $3.13B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IRON positions and 23 closed out — a net gain of 21 holders — while 94 added to existing stakes and 59 trimmed.
The largest buyer was Assenagon Asset Management, adding an estimated $55.6M. The largest seller was BVF Inc, cutting an estimated $69.5M.
- 236 institutional investors held Disc Medicine (IRON) as of Q3 2026, up from 218 in Q2 2026.
- Funds reported $2.86B of Disc Medicine stock for Q3 2026, down 8.8% quarter-over-quarter.
- 44 funds opened new Disc Medicine positions in Q3 2026 and 23 closed out, a net change of +21 holders.
- The largest Disc Medicine buyer in Q3 2026 was Assenagon Asset Management, an estimated $55.6M added.
- The largest Disc Medicine seller in Q3 2026 was BVF Inc, an estimated $69.5M sold.
Based on aggregated 13F filings for Q3 2026.